These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8937758)

  • 21. Increased cathepsin L levels in serum in some patients with ovarian cancer: comparison with CA125 and CA72-4.
    Nishida Y; Kohno K; Kawamata T; Morimitsu K; Kuwano M; Miyakawa I
    Gynecol Oncol; 1995 Mar; 56(3):357-61. PubMed ID: 7705668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of cathepsins B and L in early gestational decidua and chorionic villi].
    Wang AM; Chen SL; Xing FQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1365-8. PubMed ID: 16305957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera.
    Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J
    Clin Chim Acta; 1999 Apr; 282(1-2):211-8. PubMed ID: 10340450
    [No Abstract]   [Full Text] [Related]  

  • 24. Influence of streptozotocin- and alloxan-induced diabetes in the rat on collagenase and certain lysosomal enzymes in relation to the degradation of connective tissue proteins.
    Mohanam S; Bose SM
    Diabetologia; 1983 Jul; 25(1):66-70. PubMed ID: 6309589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assay procedures for cathepsin B, H and L activities in rat tissue homogenates.
    Higashi T; Hashimoto M; Watanabe M; Yamauchi Y; Fujiwara M; Nakatsukasa H; Kobayashi M; Watanabe A; Nagashima H
    Acta Med Okayama; 1986 Feb; 40(1):27-32. PubMed ID: 3962728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of low-risk node-negative breast cancer patients by tumor biological factors PAI-1 and cathepsin L.
    Thomssen C; Oppelt P; Jänicke F; Ulm K; Harbeck N; Höfler H; Kuhn W; Graeff H; Schmitt M
    Anticancer Res; 1998; 18(3C):2173-80. PubMed ID: 9703780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum beta-glucuronidase activity during pregnancy in gestational diabetes.
    Ferrara M; Mizrahy O; Saposhnik A; Feinstein G
    Isr J Med Sci; 1979 Sep; 15(9):746-8. PubMed ID: 511512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
    Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
    FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
    Azaryan AV; Hook VY
    Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum alkaline-stable acid thiol proteinase--a possible marker for primary liver carcinoma.
    Dufek V; Matous B; Král V
    Neoplasma; 1984; 31(1):99-107. PubMed ID: 6142423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific assay method for the activities of cathepsin L-type cysteine proteinases.
    Inubushi T; Kakegawa H; Kishino Y; Katunuma N
    J Biochem; 1994 Aug; 116(2):282-4. PubMed ID: 7822244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin V, but not cathepsins L, B and K, may release angiostatin-like fragments from plasminogen.
    Puzer L; Barros NM; Paschoalin T; Hirata IY; Tanaka AS; Oliveira MC; Brömme D; Carmona AK
    Biol Chem; 2008 Feb; 389(2):195-200. PubMed ID: 18163891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
    Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
    Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired fibrinolysis and increased protease levels in gastric and duodenal mucosa of patients with active duodenal ulcer.
    Herszènyi L; Plebani M; Carraro P; De Paoli M; Cardin R; Di Mario F; Kusstatscher S; Naccarato R; Farinati F
    Am J Gastroenterol; 1997 May; 92(5):843-7. PubMed ID: 9149198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activities of cathepsins B, D, H and L in rat heart atrial and ventricular muscle.
    Sugden PH; Lazou A
    Cardiovasc Res; 1984 Aug; 18(8):483-5. PubMed ID: 6467265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue fractionation studies. 4. Comparative study of the binding of acid phosphatase, beta-glucuronidase and cathepsin by rat-liver particles.
    GIANETTO R; DE DUVE C
    Biochem J; 1955 Mar; 59(3):433-8. PubMed ID: 14363113
    [No Abstract]   [Full Text] [Related]  

  • 37. Lymph flow and changes in intracellular enzymes during healing and rejection of rabbit skin grafts.
    Jasani MK; Lewis GP
    J Physiol; 1971 Dec; 219(3):525-54. PubMed ID: 4945593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum concentration and circadian profiles of cathepsins B, H and L, and their inhibitors, stefins A and B, in asthma.
    Cimerman N; Mesko Brguljan P; Krasovec M; Suskovic S; Kos J
    Clin Chim Acta; 2001 Aug; 310(2):113-22. PubMed ID: 11498076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased paraoxonase and arylesterase activities in the pathogenesis of future atherosclerotic heart disease in women with gestational diabetes mellitus.
    Camuzcuoglu H; Toy H; Cakir H; Celik H; Erel O
    J Womens Health (Larchmt); 2009 Sep; 18(9):1435-9. PubMed ID: 19698032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential activity of cathepsin L in human placenta at two different stages of gestation.
    Divya ; Chhikara P; Mahajan VS; Datta Gupta S; Chauhan SS
    Placenta; 2002 Jan; 23(1):59-64. PubMed ID: 11869092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.